Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas


Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas




The purpose of this study is to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin.

Study Status: Recruiting


Condition Intervention Phase
Keratoconus Device: Theralight crosslinking and Riboflavin Phase 4

Verified by Cxlusa October, 2013

Sponsored by: Cxlusa
Information provided by: Cxlusa identifier: NCT01956474

Study Type: Interventional

Study Design: Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

n/a n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit
  Information obtained from on
Link to the current record.

Cleveland Clinic Mobile Site